Tweets
-
Ignoring Starting Yields—Nabbing This “Usual Suspect” in Poor Investment Outcomes https://t.co/4DDoavaVhk via @RA_Insights -
Time perception and age: Longevity’s influence on ‘mind time’ https://t.co/4ht2QR60y0 via @bcmhouston
-
Meet the CamperForce, Amazon's Nomadic Retiree Army https://t.co/eANRZHaibb via @WIRED
-
Down $20 Billion, Boeing Stuffs Pension Fund With Its Own Shares https://t.co/q4bwG4eYBt
-
Does Immunotherapy Offer Hope to Finally End Cancer? https://t.co/ytLxfU1BUg
-
To Understand Rising Inequality, Consider the Janitors at Two Top Companies, Then and Now - https://t.co/lNemcpXG21 https://t.co/8sFs8zXpm9
-
More pieces of the annuity puzzle https://t.co/jOdsDcaVXd via @IOL
-
Annuity sales hit 16-year low amid fiduciary upheaval https://t.co/nmWv3G14zD
-
The first gene therapy for cancer has arrived in the U.S. - via @techreview https://t.co/PZFhtEuBey
-
Should we plan on living to 100? https://t.co/07YjDHMu0j
-
BlackRock Finds $5 Trillion Industry Is Now Riskier Than in '08 https://t.co/ctAKetlMMv
-
Time for longevity risk-pooling: Mercer https://t.co/g9GCNdjhlv
-
New heart treatment is biggest breakthrough since statins, scientists say https://t.co/xdjyo3aUch
-
Fiduciary Rule Requirements Disrupting Annuity Market https://t.co/niemUoQtrO
-
Hidden Debt, Hidden Deficits: 2017 Edition https://t.co/xVyLH4uci9 via @hooverinst
-
Retirees see incomes almost halve since crash https://t.co/w1KRnHnMxO
-
-
Immunotherapy succeeds in thwarting Type-1 diabetes in study https://t.co/Jwdd2IJlFA
-
She Just Won 3 Gold Medals for Her Swimming. She’s Only 73. https://t.co/F0986UyWml
-
Blockchains Get Into the Catastrophe Business https://t.co/DoQYdxBGsg
